| 1 | participate | 4,087 |
| 2 | engage | 1,109 |
| 3 | grow | 614 |
| 4 | enroll | 527 |
| 5 | accumulate | 501 |
| 6 | heal | 370 |
| 7 | intervene | 279 |
| 8 | thrive | 232 |
| 9 | conceive | 163 |
| 10 | reside | 154 |
| 11 | succeed | 154 |
| 12 | arrive | 153 |
| 13 | regress | 142 |
| 14 | proliferate | 107 |
| 15 | breathe | 55 |
| 16 | adsorb | 51 |
| 17 | crystallize | 49 |
| 18 | ambulate | 44 |
| 19 | urinate | 43 |
| 20 | circulate | 41 |
| 21 | escalate | 40 |
| 22 | ovulate | 39 |
| 23 | breast-feed | 36 |
| 24 | specialize | 30 |
| 25 | germinate | 27 |
| 26 | marry | 24 |
| 27 | defecate | 22 |
| 28 | refold | 22 |
| 29 | bioaccumulate | 17 |
| 30 | descend | 17 |
| 31 | partake | 15 |
| 32 | disintegrate | 14 |
| 33 | fertilize | 14 |
| 34 | awaken | 13 |
| 35 | first-base | 12 |
| 36 | pbw343 | 11 |
| 37 | seroconvert | 11 |
| 38 | thermoregulate | 11 |
| 39 | overeat | 9 |
| 40 | reperfuse | 9 |
| 41 | co-operate | 8 |
| 42 | dimerize | 8 |
| 43 | engraft | 8 |
| 44 | recombine | 8 |
| 45 | socialize | 8 |
| 46 | efv+3tc-zdv | 7 |
| 47 | indulge | 7 |
| 48 | mutate | 7 |
| 49 | re-emerge | 7 |
| 50 | re-engage | 7 |
| 51 | suckle | 7 |
| 52 | vaporize | 7 |
| 53 | calve | 6 |
| 54 | confide | 6 |
| 55 | extravasate | 6 |
| 56 | misfold | 6 |
| 57 | abscise | 5 |
| 58 | menstruate | 5 |
| 59 | miscarry | 5 |
| 60 | reciprocate | 5 |
| 61 | regrow | 5 |
| 62 | reintegrate | 5 |
| 63 | self-weigh | 5 |
| 64 | +0.96 | 4 |
| 65 | bask | 4 |
| 66 | bet-1 | 4 |
| 67 | farrow | 4 |
| 68 | micturate | 4 |
| 69 | postchange | 4 |
| 70 | pupate | 4 |
| 71 | reinvest | 4 |
| 72 | 0.2±0.5 | 3 |
| 73 | 4pm | 3 |
| 74 | autophosphorylate | 3 |
| 75 | chop/21 | 3 |
| 76 | co-circulate | 3 |
| 77 | coassemble | 3 |
| 78 | colophonium | 3 |
| 79 | crumble | 3 |
| 80 | disbelieve | 3 |
| 81 | mucosalization | 3 |
| 82 | neurorepair | 3 |
| 83 | nt10 | 3 |
| 84 | overgrow | 3 |
| 85 | photo-stability | 3 |
| 86 | posttitration | 3 |
| 87 | re-enroll | 3 |
| 88 | sirolimus-mmf | 3 |
| 89 | sogd | 3 |
| 90 | sporulate | 3 |
| 91 | supine-wedged | 3 |
| 92 | thermofilum | 3 |
| 93 | vd₃ | 3 |
| 94 | δscore | 3 |
| 95 | ≥20° | 3 |
| 96 | 1.2mg/ml | 2 |
| 97 | 117° | 2 |
| 98 | 120/100,000 | 2 |
| 99 | 123/min | 2 |
| 100 | 142/100,000 | 2 |
| 101 | 155/100,000 | 2 |
| 102 | 217.0 | 2 |
| 103 | 3',5'-cnmps | 2 |
| 104 | 3-bromo-l-tyrosine | 2 |
| 105 | 32/100,000 | 2 |
| 106 | 328.86 | 2 |
| 107 | 4.25° | 2 |
| 108 | 4.9/1,000 | 2 |
| 109 | 40,429 | 2 |
| 110 | 44/1000 | 2 |
| 111 | 6microm | 2 |
| 112 | 74,887 | 2 |
| 113 | 90.64±9.47 | 2 |
| 114 | bipreterax | 2 |
| 115 | cel5a-xylt | 2 |
| 116 | chlorophthalazines | 2 |
| 117 | co-assemble | 2 |
| 118 | coapt | 2 |
| 119 | ed11 | 2 |
| 120 | fathom | 2 |
| 121 | feasable | 2 |
| 122 | fitc-lps | 2 |
| 123 | for-pla | 2 |
| 124 | freeze-injury | 2 |
| 125 | gb3-18 | 2 |
| 126 | heading8 | 2 |
| 127 | hyperpolarize | 2 |
| 128 | hyperthemia | 2 |
| 129 | immunodysregulation | 2 |
| 130 | intercede | 2 |
| 131 | leptocheirus | 2 |
| 132 | locomote | 2 |
| 133 | m1-cis | 2 |
| 134 | myeloproliferation | 2 |
| 135 | oxyphyllacinol | 2 |
| 136 | post-changes | 2 |
| 137 | pupating | 2 |
| 138 | re-form | 2 |
| 139 | re-grow | 2 |
| 140 | redonate | 2 |
| 141 | schröder | 2 |
| 142 | scs/sccs | 2 |
| 143 | self-aggregate | 2 |
| 144 | self-enroll | 2 |
| 145 | titusville | 2 |
| 146 | up-dose | 2 |
| 147 | vamp2 | 2 |
| 148 | α-chitin | 2 |
| 149 | 'blend | 1 |
| 150 | +0.040±0.094 | 1 |
| 151 | +0.15˚c | 1 |
| 152 | +0.29˚c | 1 |
| 153 | +20k | 1 |
| 154 | +966 | 1 |
| 155 | -0.031±0.090 | 1 |
| 156 | -0.1±0.3 | 1 |
| 157 | -1.1°c | 1 |
| 158 | 0.109±0.067 | 1 |
| 159 | 0.152±0.090 | 1 |
| 160 | 0.3267 | 1 |
| 161 | 0.3483 | 1 |
| 162 | 0.37±0.02 | 1 |
| 163 | 0.5+/-0.9 | 1 |
| 164 | 0.52min | 1 |
| 165 | 0.63/100,000 | 1 |
| 166 | 0.63±0.04 | 1 |
| 167 | 0.65±0.14 | 1 |
| 168 | 0.71-fold | 1 |
| 169 | 0.72+/-0.2 | 1 |
| 170 | 0.87/0.9 | 1 |
| 171 | 0.95-1 | 1 |
| 172 | 0.9971 | 1 |
| 173 | 0.99±0.17 | 1 |
| 174 | 0/41 | 1 |
| 175 | 06:00hs | 1 |
| 176 | 1,017,000 | 1 |
| 177 | 1,3-bis-2-chloroethylnitrosourea | 1 |
| 178 | 1,417,000 | 1 |
| 179 | 1.1/week | 1 |
| 180 | 1.2ppmv | 1 |
| 181 | 1.397 | 1 |
| 182 | 1.4±1.5 | 1 |
| 183 | 1.5+/-0.6 | 1 |
| 184 | 1.61±0.58m/s | 1 |
| 185 | 1.6ng/ml | 1 |
| 186 | 1.70±0.61 | 1 |
| 187 | 1.75±0.296 | 1 |
| 188 | 10,074,951 | 1 |
| 189 | 10.9±4.5 | 1 |
| 190 | 1010/ml | 1 |
| 191 | 1012/ml | 1 |
| 192 | 106.25 | 1 |
| 193 | 10·57 | 1 |
| 194 | 11,835 | 1 |
| 195 | 11.000 | 1 |
| 196 | 11.7±5.8 | 1 |
| 197 | 118±11min | 1 |
| 198 | 12.0+/-9.5 | 1 |
| 199 | 12.3±6.8 | 1 |
| 200 | 12.5±4.6 | 1 |
| 201 | 12.9+0.1 | 1 |
| 202 | 121,055 | 1 |
| 203 | 127.6/79.7 | 1 |
| 204 | 13.25+/-10.87 | 1 |
| 205 | 13.5+/-10.0 | 1 |
| 206 | 14.4µg/ml | 1 |
| 207 | 140/76 | 1 |
| 208 | 142days | 1 |
| 209 | 151.4/93.6 | 1 |
| 210 | 152.4/89.5 | 1 |
| 211 | 162/100,000 | 1 |
| 212 | 16950euro | 1 |
| 213 | 17.27° | 1 |
| 214 | 187h | 1 |
| 215 | 193.2±14.4 | 1 |
| 216 | 1:1.52 | 1 |
| 217 | 2,035,000 | 1 |
| 218 | 2,3'-bisindoles | 1 |
| 219 | 2,422,298 | 1 |
| 220 | 2,525 | 1 |
| 221 | 2-amp | 1 |
| 222 | 2.14±0.96 | 1 |
| 223 | 2.18±0.88 | 1 |
| 224 | 2.47/h | 1 |
| 225 | 2.62+/-0.44 | 1 |
| 226 | 2.79+/-0.47 | 1 |
| 227 | 20,841 | 1 |
| 228 | 200ng/ml | 1 |
| 229 | 211mcg/day | 1 |
| 230 | 239.89 | 1 |
| 231 | 24.7min | 1 |
| 232 | 27.1mm | 1 |
| 233 | 27109 | 1 |
| 234 | 28,664,796 | 1 |
| 235 | 2e/3 | 1 |
| 236 | 3-acylfurans | 1 |
| 237 | 3-cyano-4,5-dihydro-1h-pyrroles | 1 |
| 238 | 3.04+/-1.09 | 1 |
| 239 | 3.10+/-0.84 | 1 |
| 240 | 3.2+/-0.1 | 1 |
| 241 | 3.8+/-3 | 1 |
| 242 | 3.9±1.7 | 1 |
| 243 | 300‑fold | 1 |
| 244 | 304.50 | 1 |
| 245 | 315.76±140.00μg/l | 1 |
| 246 | 33.8+/-15.0 | 1 |
| 247 | 330.8 | 1 |
| 248 | 3573+/-187 | 1 |
| 249 | 36.3+/-13.1 | 1 |
| 250 | 370.41±91.56m | 1 |
| 251 | 370mgi/ml | 1 |
| 252 | 39.5±0.2°c | 1 |
| 253 | 3±0.84 | 1 |
| 254 | 4,933,000 | 1 |
| 255 | 4.1+/-2.6 | 1 |
| 256 | 4.8±0.5 | 1 |
| 257 | 4.8±2.8 | 1 |
| 258 | 4.95/h | 1 |
| 259 | 41.5/1000 | 1 |
| 260 | 43.6g/l | 1 |
| 261 | 44/100,000 | 1 |
| 262 | 44gpa | 1 |
| 263 | 45.75±24 | 1 |
| 264 | 4500mg/day | 1 |
| 265 | 493/month | 1 |
| 266 | 5-fu-cisplatin | 1 |
| 267 | 5.0±2.0 | 1 |
| 268 | 5.0±2.5 | 1 |
| 269 | 5.6h | 1 |
| 270 | 5.98±0.94 | 1 |
| 271 | 5000ng/ml | 1 |
| 272 | 53,027 | 1 |
| 273 | 54.7°c | 1 |
| 274 | 58.2+/-36.9 | 1 |
| 275 | 59.9/1000 | 1 |
| 276 | 5fu/leucovorin | 1 |
| 277 | 5±1.7 | 1 |
| 278 | 6,911 | 1 |
| 279 | 6.52∓2.37 | 1 |
| 280 | 6000μg/g | 1 |
| 281 | 63days | 1 |
| 282 | 64.1±17.3 | 1 |
| 283 | 659.3 | 1 |
| 284 | 683.44 | 1 |
| 285 | 68h | 1 |
| 286 | 7.2/1000 | 1 |
| 287 | 7.2±1.8 | 1 |
| 288 | 7.7±0.9 | 1 |
| 289 | 700-fold | 1 |
| 290 | 72,411 | 1 |
| 291 | 7452 | 1 |
| 292 | 77,108 | 1 |
| 293 | 78.2±12.4 | 1 |
| 294 | 8.0+/-8.5 | 1 |
| 295 | 8.49∓3.53 | 1 |
| 296 | 8.67±1.70s | 1 |
| 297 | 9-years-old | 1 |
| 298 | 9.1+/-3.7 | 1 |
| 299 | 9.12-8.81 | 1 |
| 300 | 920ºc | 1 |
| 301 | 936/mmc | 1 |
| 302 | 95±4 | 1 |
| 303 | 96.22±5.35 | 1 |
| 304 | 97,245 | 1 |
| 305 | ad-oxytosis | 1 |
| 306 | afro-trinidadians | 1 |
| 307 | alkyl-naphthalenes | 1 |
| 308 | antimicrobians | 1 |
| 309 | apobh | 1 |
| 310 | autoactivate | 1 |
| 311 | autosegment | 1 |
| 312 | beta-blocker/thiazide | 1 |
| 313 | brownish-black | 1 |
| 314 | c3-epi-cholecalciferol | 1 |
| 315 | cc-gonadotropin | 1 |
| 316 | ceftadizime | 1 |
| 317 | chest-level | 1 |
| 318 | chloramphenicol/dexamethasone | 1 |
| 319 | co-participate | 1 |
| 320 | coda-cerva | 1 |
| 321 | cu-no2 | 1 |
| 322 | cyclohexadiene | 1 |
| 323 | cyclosporine-neoral | 1 |
| 324 | d16s419 | 1 |
| 325 | date-five | 1 |
| 326 | depoliticize | 1 |
| 327 | det1-specific | 1 |
| 328 | dilate/stiffen | 1 |
| 329 | dis-temperament | 1 |
| 330 | disbud | 1 |
| 331 | dose-reductions | 1 |
| 332 | eehv1a | 1 |
| 333 | electrocardiographic-gating | 1 |
| 334 | en14362-1:2012 | 1 |
| 335 | ensile | 1 |
| 336 | equitoxicity | 1 |
| 337 | etancercept | 1 |
| 338 | euro50,000 | 1 |
| 339 | extraction/exfoliation | 1 |
| 340 | fibrillate | 1 |
| 341 | fmk1 | 1 |
| 342 | follow-up-assessment | 1 |
| 343 | followup/withdrawals | 1 |
| 344 | g34w/l | 1 |
| 345 | gelatinise | 1 |
| 346 | glibenclamide+rosuvastatin | 1 |
| 347 | grand-offspring | 1 |
| 348 | h+/k+/atpase | 1 |
| 349 | hallucinate | 1 |
| 350 | hclo4 | 1 |
| 351 | implantation/randomization | 1 |
| 352 | improvement/reduction | 1 |
| 353 | intervention-response | 1 |
| 354 | invalidities | 1 |
| 355 | laparotomise | 1 |
| 356 | liquidify | 1 |
| 357 | meningitec® | 1 |
| 358 | metal-nps | 1 |
| 359 | metoform | 1 |
| 360 | moderate/light | 1 |
| 361 | modify/titrate | 1 |
| 362 | month18 | 1 |
| 363 | n-h-1,3-aminoalcohols | 1 |
| 364 | n229 | 1 |
| 365 | neoreflux | 1 |
| 366 | non-amlodipine-dhp-ccbs | 1 |
| 367 | non-autistics | 1 |
| 368 | ovario-hysterectomy | 1 |
| 369 | overpack | 1 |
| 370 | oxupurinol | 1 |
| 371 | peridomiciles | 1 |
| 372 | phase-shifts | 1 |
| 373 | placebo+p/r | 1 |
| 374 | placebo/controls | 1 |
| 375 | placebo/peg | 1 |
| 376 | playbacks | 1 |
| 377 | post-decrease | 1 |
| 378 | post-evaluations | 1 |
| 379 | postvalues | 1 |
| 380 | pressurise | 1 |
| 381 | r230 | 1 |
| 382 | re-cycling | 1 |
| 383 | re-enrol | 1 |
| 384 | reattach | 1 |
| 385 | reducion | 1 |
| 386 | reenroll | 1 |
| 387 | relook | 1 |
| 388 | restingas | 1 |
| 389 | rr-hf | 1 |
| 390 | rt-pa/aspirin | 1 |
| 391 | scd/va | 1 |
| 392 | snarls | 1 |
| 393 | st466 | 1 |
| 394 | stress/senescence | 1 |
| 395 | sub-diffusion | 1 |
| 396 | sub-investigators | 1 |
| 397 | sub-μg | 1 |
| 398 | subconfluency | 1 |
| 399 | sunbathe | 1 |
| 400 | tac/csa | 1 |
| 401 | tp53-mutations | 1 |
| 402 | trichomanads | 1 |
| 403 | trivial-mild | 1 |
| 404 | turbulences | 1 |
| 405 | ukrs | 1 |
| 406 | underheating | 1 |
| 407 | val75 | 1 |
| 408 | vam-hldn | 1 |
| 409 | vancomycin/aztreonam | 1 |
| 410 | £54,607 | 1 |
| 411 | ±20° | 1 |
| 412 | λ/3968 | 1 |
| 413 | €1708 | 1 |
| 414 | €32.23 | 1 |
| 415 | €6123 | 1 |
| 1 | 'blend | 1 |
| 2 | +0.040±0.094 | 1 |
| 3 | +0.15˚c | 1 |
| 4 | +0.29˚c | 1 |
| 5 | +0.96 | 4 |
| 6 | +20k | 1 |
| 7 | +966 | 1 |
| 8 | -0.031±0.090 | 1 |
| 9 | -0.1±0.3 | 1 |
| 10 | -1.1°c | 1 |
| 11 | 0.109±0.067 | 1 |
| 12 | 0.152±0.090 | 1 |
| 13 | 0.2±0.5 | 3 |
| 14 | 0.3267 | 1 |
| 15 | 0.3483 | 1 |
| 16 | 0.37±0.02 | 1 |
| 17 | 0.5+/-0.9 | 1 |
| 18 | 0.52min | 1 |
| 19 | 0.63/100,000 | 1 |
| 20 | 0.63±0.04 | 1 |
| 21 | 0.65±0.14 | 1 |
| 22 | 0.71-fold | 1 |
| 23 | 0.72+/-0.2 | 1 |
| 24 | 0.87/0.9 | 1 |
| 25 | 0.95-1 | 1 |
| 26 | 0.9971 | 1 |
| 27 | 0.99±0.17 | 1 |
| 28 | 0/41 | 1 |
| 29 | 06:00hs | 1 |
| 30 | 1,017,000 | 1 |
| 31 | 1,3-bis-2-chloroethylnitrosourea | 1 |
| 32 | 1,417,000 | 1 |
| 33 | 1.1/week | 1 |
| 34 | 1.2mg/ml | 2 |
| 35 | 1.2ppmv | 1 |
| 36 | 1.397 | 1 |
| 37 | 1.4±1.5 | 1 |
| 38 | 1.5+/-0.6 | 1 |
| 39 | 1.61±0.58m/s | 1 |
| 40 | 1.6ng/ml | 1 |
| 41 | 1.70±0.61 | 1 |
| 42 | 1.75±0.296 | 1 |
| 43 | 10,074,951 | 1 |
| 44 | 10.9±4.5 | 1 |
| 45 | 1010/ml | 1 |
| 46 | 1012/ml | 1 |
| 47 | 106.25 | 1 |
| 48 | 10·57 | 1 |
| 49 | 11,835 | 1 |
| 50 | 11.000 | 1 |
| 51 | 11.7±5.8 | 1 |
| 52 | 117° | 2 |
| 53 | 118±11min | 1 |
| 54 | 12.0+/-9.5 | 1 |
| 55 | 12.3±6.8 | 1 |
| 56 | 12.5±4.6 | 1 |
| 57 | 12.9+0.1 | 1 |
| 58 | 120/100,000 | 2 |
| 59 | 121,055 | 1 |
| 60 | 123/min | 2 |
| 61 | 127.6/79.7 | 1 |
| 62 | 13.25+/-10.87 | 1 |
| 63 | 13.5+/-10.0 | 1 |
| 64 | 14.4µg/ml | 1 |
| 65 | 140/76 | 1 |
| 66 | 142/100,000 | 2 |
| 67 | 142days | 1 |
| 68 | 151.4/93.6 | 1 |
| 69 | 152.4/89.5 | 1 |
| 70 | 155/100,000 | 2 |
| 71 | 162/100,000 | 1 |
| 72 | 16950euro | 1 |
| 73 | 17.27° | 1 |
| 74 | 187h | 1 |
| 75 | 193.2±14.4 | 1 |
| 76 | 1:1.52 | 1 |
| 77 | 2,035,000 | 1 |
| 78 | 2,3'-bisindoles | 1 |
| 79 | 2,422,298 | 1 |
| 80 | 2,525 | 1 |
| 81 | 2-amp | 1 |
| 82 | 2.14±0.96 | 1 |
| 83 | 2.18±0.88 | 1 |
| 84 | 2.47/h | 1 |
| 85 | 2.62+/-0.44 | 1 |
| 86 | 2.79+/-0.47 | 1 |
| 87 | 20,841 | 1 |
| 88 | 200ng/ml | 1 |
| 89 | 211mcg/day | 1 |
| 90 | 217.0 | 2 |
| 91 | 239.89 | 1 |
| 92 | 24.7min | 1 |
| 93 | 27.1mm | 1 |
| 94 | 27109 | 1 |
| 95 | 28,664,796 | 1 |
| 96 | 2e/3 | 1 |
| 97 | 3',5'-cnmps | 2 |
| 98 | 3-acylfurans | 1 |
| 99 | 3-bromo-l-tyrosine | 2 |
| 100 | 3-cyano-4,5-dihydro-1h-pyrroles | 1 |
| 101 | 3.04+/-1.09 | 1 |
| 102 | 3.10+/-0.84 | 1 |
| 103 | 3.2+/-0.1 | 1 |
| 104 | 3.8+/-3 | 1 |
| 105 | 3.9±1.7 | 1 |
| 106 | 300‑fold | 1 |
| 107 | 304.50 | 1 |
| 108 | 315.76±140.00μg/l | 1 |
| 109 | 32/100,000 | 2 |
| 110 | 328.86 | 2 |
| 111 | 33.8+/-15.0 | 1 |
| 112 | 330.8 | 1 |
| 113 | 3573+/-187 | 1 |
| 114 | 36.3+/-13.1 | 1 |
| 115 | 370.41±91.56m | 1 |
| 116 | 370mgi/ml | 1 |
| 117 | 39.5±0.2°c | 1 |
| 118 | 3±0.84 | 1 |
| 119 | 4,933,000 | 1 |
| 120 | 4.1+/-2.6 | 1 |
| 121 | 4.25° | 2 |
| 122 | 4.8±0.5 | 1 |
| 123 | 4.8±2.8 | 1 |
| 124 | 4.9/1,000 | 2 |
| 125 | 4.95/h | 1 |
| 126 | 40,429 | 2 |
| 127 | 41.5/1000 | 1 |
| 128 | 43.6g/l | 1 |
| 129 | 44/100,000 | 1 |
| 130 | 44/1000 | 2 |
| 131 | 44gpa | 1 |
| 132 | 45.75±24 | 1 |
| 133 | 4500mg/day | 1 |
| 134 | 493/month | 1 |
| 135 | 4pm | 3 |
| 136 | 5-fu-cisplatin | 1 |
| 137 | 5.0±2.0 | 1 |
| 138 | 5.0±2.5 | 1 |
| 139 | 5.6h | 1 |
| 140 | 5.98±0.94 | 1 |
| 141 | 5000ng/ml | 1 |
| 142 | 53,027 | 1 |
| 143 | 54.7°c | 1 |
| 144 | 58.2+/-36.9 | 1 |
| 145 | 59.9/1000 | 1 |
| 146 | 5fu/leucovorin | 1 |
| 147 | 5±1.7 | 1 |
| 148 | 6,911 | 1 |
| 149 | 6.52∓2.37 | 1 |
| 150 | 6000μg/g | 1 |
| 151 | 63days | 1 |
| 152 | 64.1±17.3 | 1 |
| 153 | 659.3 | 1 |
| 154 | 683.44 | 1 |
| 155 | 68h | 1 |
| 156 | 6microm | 2 |
| 157 | 7.2/1000 | 1 |
| 158 | 7.2±1.8 | 1 |
| 159 | 7.7±0.9 | 1 |
| 160 | 700-fold | 1 |
| 161 | 72,411 | 1 |
| 162 | 74,887 | 2 |
| 163 | 7452 | 1 |
| 164 | 77,108 | 1 |
| 165 | 78.2±12.4 | 1 |
| 166 | 8.0+/-8.5 | 1 |
| 167 | 8.49∓3.53 | 1 |
| 168 | 8.67±1.70s | 1 |
| 169 | 9-years-old | 1 |
| 170 | 9.1+/-3.7 | 1 |
| 171 | 9.12-8.81 | 1 |
| 172 | 90.64±9.47 | 2 |
| 173 | 920ºc | 1 |
| 174 | 936/mmc | 1 |
| 175 | 95±4 | 1 |
| 176 | 96.22±5.35 | 1 |
| 177 | 97,245 | 1 |
| 178 | abscise | 5 |
| 179 | accumulate | 501 |
| 180 | ad-oxytosis | 1 |
| 181 | adsorb | 51 |
| 182 | afro-trinidadians | 1 |
| 183 | alkyl-naphthalenes | 1 |
| 184 | ambulate | 44 |
| 185 | antimicrobians | 1 |
| 186 | apobh | 1 |
| 187 | arrive | 153 |
| 188 | autoactivate | 1 |
| 189 | autophosphorylate | 3 |
| 190 | autosegment | 1 |
| 191 | awaken | 13 |
| 192 | bask | 4 |
| 193 | bet-1 | 4 |
| 194 | beta-blocker/thiazide | 1 |
| 195 | bioaccumulate | 17 |
| 196 | bipreterax | 2 |
| 197 | breast-feed | 36 |
| 198 | breathe | 55 |
| 199 | brownish-black | 1 |
| 200 | c3-epi-cholecalciferol | 1 |
| 201 | calve | 6 |
| 202 | cc-gonadotropin | 1 |
| 203 | ceftadizime | 1 |
| 204 | cel5a-xylt | 2 |
| 205 | chest-level | 1 |
| 206 | chloramphenicol/dexamethasone | 1 |
| 207 | chlorophthalazines | 2 |
| 208 | chop/21 | 3 |
| 209 | circulate | 41 |
| 210 | co-assemble | 2 |
| 211 | co-circulate | 3 |
| 212 | co-operate | 8 |
| 213 | co-participate | 1 |
| 214 | coapt | 2 |
| 215 | coassemble | 3 |
| 216 | coda-cerva | 1 |
| 217 | colophonium | 3 |
| 218 | conceive | 163 |
| 219 | confide | 6 |
| 220 | crumble | 3 |
| 221 | crystallize | 49 |
| 222 | cu-no2 | 1 |
| 223 | cyclohexadiene | 1 |
| 224 | cyclosporine-neoral | 1 |
| 225 | d16s419 | 1 |
| 226 | date-five | 1 |
| 227 | defecate | 22 |
| 228 | depoliticize | 1 |
| 229 | descend | 17 |
| 230 | det1-specific | 1 |
| 231 | dilate/stiffen | 1 |
| 232 | dimerize | 8 |
| 233 | dis-temperament | 1 |
| 234 | disbelieve | 3 |
| 235 | disbud | 1 |
| 236 | disintegrate | 14 |
| 237 | dose-reductions | 1 |
| 238 | ed11 | 2 |
| 239 | eehv1a | 1 |
| 240 | efv+3tc-zdv | 7 |
| 241 | electrocardiographic-gating | 1 |
| 242 | en14362-1:2012 | 1 |
| 243 | engage | 1,109 |
| 244 | engraft | 8 |
| 245 | enroll | 527 |
| 246 | ensile | 1 |
| 247 | equitoxicity | 1 |
| 248 | escalate | 40 |
| 249 | etancercept | 1 |
| 250 | euro50,000 | 1 |
| 251 | extraction/exfoliation | 1 |
| 252 | extravasate | 6 |
| 253 | farrow | 4 |
| 254 | fathom | 2 |
| 255 | feasable | 2 |
| 256 | fertilize | 14 |
| 257 | fibrillate | 1 |
| 258 | first-base | 12 |
| 259 | fitc-lps | 2 |
| 260 | fmk1 | 1 |
| 261 | follow-up-assessment | 1 |
| 262 | followup/withdrawals | 1 |
| 263 | for-pla | 2 |
| 264 | freeze-injury | 2 |
| 265 | g34w/l | 1 |
| 266 | gb3-18 | 2 |
| 267 | gelatinise | 1 |
| 268 | germinate | 27 |
| 269 | glibenclamide+rosuvastatin | 1 |
| 270 | grand-offspring | 1 |
| 271 | grow | 614 |
| 272 | h+/k+/atpase | 1 |
| 273 | hallucinate | 1 |
| 274 | hclo4 | 1 |
| 275 | heading8 | 2 |
| 276 | heal | 370 |
| 277 | hyperpolarize | 2 |
| 278 | hyperthemia | 2 |
| 279 | immunodysregulation | 2 |
| 280 | implantation/randomization | 1 |
| 281 | improvement/reduction | 1 |
| 282 | indulge | 7 |
| 283 | intercede | 2 |
| 284 | intervene | 279 |
| 285 | intervention-response | 1 |
| 286 | invalidities | 1 |
| 287 | laparotomise | 1 |
| 288 | leptocheirus | 2 |
| 289 | liquidify | 1 |
| 290 | locomote | 2 |
| 291 | m1-cis | 2 |
| 292 | marry | 24 |
| 293 | meningitec® | 1 |
| 294 | menstruate | 5 |
| 295 | metal-nps | 1 |
| 296 | metoform | 1 |
| 297 | micturate | 4 |
| 298 | miscarry | 5 |
| 299 | misfold | 6 |
| 300 | moderate/light | 1 |
| 301 | modify/titrate | 1 |
| 302 | month18 | 1 |
| 303 | mucosalization | 3 |
| 304 | mutate | 7 |
| 305 | myeloproliferation | 2 |
| 306 | n-h-1,3-aminoalcohols | 1 |
| 307 | n229 | 1 |
| 308 | neoreflux | 1 |
| 309 | neurorepair | 3 |
| 310 | non-amlodipine-dhp-ccbs | 1 |
| 311 | non-autistics | 1 |
| 312 | nt10 | 3 |
| 313 | ovario-hysterectomy | 1 |
| 314 | overeat | 9 |
| 315 | overgrow | 3 |
| 316 | overpack | 1 |
| 317 | ovulate | 39 |
| 318 | oxupurinol | 1 |
| 319 | oxyphyllacinol | 2 |
| 320 | partake | 15 |
| 321 | participate | 4,087 |
| 322 | pbw343 | 11 |
| 323 | peridomiciles | 1 |
| 324 | phase-shifts | 1 |
| 325 | photo-stability | 3 |
| 326 | placebo+p/r | 1 |
| 327 | placebo/controls | 1 |
| 328 | placebo/peg | 1 |
| 329 | playbacks | 1 |
| 330 | post-changes | 2 |
| 331 | post-decrease | 1 |
| 332 | post-evaluations | 1 |
| 333 | postchange | 4 |
| 334 | posttitration | 3 |
| 335 | postvalues | 1 |
| 336 | pressurise | 1 |
| 337 | proliferate | 107 |
| 338 | pupate | 4 |
| 339 | pupating | 2 |
| 340 | r230 | 1 |
| 341 | re-cycling | 1 |
| 342 | re-emerge | 7 |
| 343 | re-engage | 7 |
| 344 | re-enrol | 1 |
| 345 | re-enroll | 3 |
| 346 | re-form | 2 |
| 347 | re-grow | 2 |
| 348 | reattach | 1 |
| 349 | reciprocate | 5 |
| 350 | recombine | 8 |
| 351 | redonate | 2 |
| 352 | reducion | 1 |
| 353 | reenroll | 1 |
| 354 | refold | 22 |
| 355 | regress | 142 |
| 356 | regrow | 5 |
| 357 | reintegrate | 5 |
| 358 | reinvest | 4 |
| 359 | relook | 1 |
| 360 | reperfuse | 9 |
| 361 | reside | 154 |
| 362 | restingas | 1 |
| 363 | rr-hf | 1 |
| 364 | rt-pa/aspirin | 1 |
| 365 | scd/va | 1 |
| 366 | schröder | 2 |
| 367 | scs/sccs | 2 |
| 368 | self-aggregate | 2 |
| 369 | self-enroll | 2 |
| 370 | self-weigh | 5 |
| 371 | seroconvert | 11 |
| 372 | sirolimus-mmf | 3 |
| 373 | snarls | 1 |
| 374 | socialize | 8 |
| 375 | sogd | 3 |
| 376 | specialize | 30 |
| 377 | sporulate | 3 |
| 378 | st466 | 1 |
| 379 | stress/senescence | 1 |
| 380 | sub-diffusion | 1 |
| 381 | sub-investigators | 1 |
| 382 | sub-μg | 1 |
| 383 | subconfluency | 1 |
| 384 | succeed | 154 |
| 385 | suckle | 7 |
| 386 | sunbathe | 1 |
| 387 | supine-wedged | 3 |
| 388 | tac/csa | 1 |
| 389 | thermofilum | 3 |
| 390 | thermoregulate | 11 |
| 391 | thrive | 232 |
| 392 | titusville | 2 |
| 393 | tp53-mutations | 1 |
| 394 | trichomanads | 1 |
| 395 | trivial-mild | 1 |
| 396 | turbulences | 1 |
| 397 | ukrs | 1 |
| 398 | underheating | 1 |
| 399 | up-dose | 2 |
| 400 | urinate | 43 |
| 401 | val75 | 1 |
| 402 | vam-hldn | 1 |
| 403 | vamp2 | 2 |
| 404 | vancomycin/aztreonam | 1 |
| 405 | vaporize | 7 |
| 406 | vd₃ | 3 |
| 407 | £54,607 | 1 |
| 408 | ±20° | 1 |
| 409 | α-chitin | 2 |
| 410 | δscore | 3 |
| 411 | λ/3968 | 1 |
| 412 | €1708 | 1 |
| 413 | €32.23 | 1 |
| 414 | €6123 | 1 |
| 415 | ≥20° | 3 |
| 1 | 13.5+/-10.0 | 1 |
| 2 | 5.0±2.0 | 1 |
| 3 | 33.8+/-15.0 | 1 |
| 4 | 217.0 | 2 |
| 5 | 120/100,000 | 2 |
| 6 | 32/100,000 | 2 |
| 7 | 142/100,000 | 2 |
| 8 | 162/100,000 | 1 |
| 9 | 0.63/100,000 | 1 |
| 10 | 44/100,000 | 1 |
| 11 | 155/100,000 | 2 |
| 12 | euro50,000 | 1 |
| 13 | 4.9/1,000 | 2 |
| 14 | 4,933,000 | 1 |
| 15 | 2,035,000 | 1 |
| 16 | 1,017,000 | 1 |
| 17 | 1,417,000 | 1 |
| 18 | 11.000 | 1 |
| 19 | 7.2/1000 | 1 |
| 20 | 44/1000 | 2 |
| 21 | 41.5/1000 | 1 |
| 22 | 59.9/1000 | 1 |
| 23 | nt10 | 3 |
| 24 | r230 | 1 |
| 25 | 304.50 | 1 |
| 26 | -0.031±0.090 | 1 |
| 27 | 0.152±0.090 | 1 |
| 28 | 0.95-1 | 1 |
| 29 | bet-1 | 4 |
| 30 | 12.9+0.1 | 1 |
| 31 | 3.2+/-0.1 | 1 |
| 32 | 36.3+/-13.1 | 1 |
| 33 | 72,411 | 1 |
| 34 | 6,911 | 1 |
| 35 | ed11 | 2 |
| 36 | chop/21 | 3 |
| 37 | 0/41 | 1 |
| 38 | 20,841 | 1 |
| 39 | 10,074,951 | 1 |
| 40 | 1.70±0.61 | 1 |
| 41 | 0.9971 | 1 |
| 42 | 9.12-8.81 | 1 |
| 43 | fmk1 | 1 |
| 44 | 0.72+/-0.2 | 1 |
| 45 | 0.37±0.02 | 1 |
| 46 | en14362-1:2012 | 1 |
| 47 | 1:1.52 | 1 |
| 48 | 7452 | 1 |
| 49 | cu-no2 | 1 |
| 50 | vamp2 | 2 |
| 51 | 3.8+/-3 | 1 |
| 52 | -0.1±0.3 | 1 |
| 53 | 64.1±17.3 | 1 |
| 54 | 659.3 | 1 |
| 55 | 2e/3 | 1 |
| 56 | €32.23 | 1 |
| 57 | €6123 | 1 |
| 58 | pbw343 | 11 |
| 59 | 8.49∓3.53 | 1 |
| 60 | 0.3483 | 1 |
| 61 | 78.2±12.4 | 1 |
| 62 | 193.2±14.4 | 1 |
| 63 | 0.63±0.04 | 1 |
| 64 | 0.65±0.14 | 1 |
| 65 | 45.75±24 | 1 |
| 66 | 2.62+/-0.44 | 1 |
| 67 | 683.44 | 1 |
| 68 | 3.10+/-0.84 | 1 |
| 69 | 3±0.84 | 1 |
| 70 | 5.98±0.94 | 1 |
| 71 | +0.040±0.094 | 1 |
| 72 | hclo4 | 1 |
| 73 | 95±4 | 1 |
| 74 | 0.2±0.5 | 3 |
| 75 | 4.8±0.5 | 1 |
| 76 | 1.4±1.5 | 1 |
| 77 | 5.0±2.5 | 1 |
| 78 | 10.9±4.5 | 1 |
| 79 | 8.0+/-8.5 | 1 |
| 80 | 12.0+/-9.5 | 1 |
| 81 | 152.4/89.5 | 1 |
| 82 | 106.25 | 1 |
| 83 | 2,525 | 1 |
| 84 | 96.22±5.35 | 1 |
| 85 | 11,835 | 1 |
| 86 | 97,245 | 1 |
| 87 | 121,055 | 1 |
| 88 | val75 | 1 |
| 89 | 1.5+/-0.6 | 1 |
| 90 | 4.1+/-2.6 | 1 |
| 91 | 151.4/93.6 | 1 |
| 92 | 12.5±4.6 | 1 |
| 93 | st466 | 1 |
| 94 | +966 | 1 |
| 95 | 140/76 | 1 |
| 96 | 328.86 | 2 |
| 97 | +0.96 | 4 |
| 98 | 2.14±0.96 | 1 |
| 99 | 1.75±0.296 | 1 |
| 100 | 28,664,796 | 1 |
| 101 | 5±1.7 | 1 |
| 102 | 3.9±1.7 | 1 |
| 103 | 9.1+/-3.7 | 1 |
| 104 | 127.6/79.7 | 1 |
| 105 | £54,607 | 1 |
| 106 | 0.99±0.17 | 1 |
| 107 | 53,027 | 1 |
| 108 | 6.52∓2.37 | 1 |
| 109 | 2.79+/-0.47 | 1 |
| 110 | 90.64±9.47 | 2 |
| 111 | 10·57 | 1 |
| 112 | 0.109±0.067 | 1 |
| 113 | 0.3267 | 1 |
| 114 | 13.25+/-10.87 | 1 |
| 115 | 3573+/-187 | 1 |
| 116 | 74,887 | 2 |
| 117 | 1.397 | 1 |
| 118 | 330.8 | 1 |
| 119 | 7.2±1.8 | 1 |
| 120 | 4.8±2.8 | 1 |
| 121 | 11.7±5.8 | 1 |
| 122 | 12.3±6.8 | 1 |
| 123 | 77,108 | 1 |
| 124 | €1708 | 1 |
| 125 | gb3-18 | 2 |
| 126 | month18 | 1 |
| 127 | λ/3968 | 1 |
| 128 | 2.18±0.88 | 1 |
| 129 | 2,422,298 | 1 |
| 130 | heading8 | 2 |
| 131 | 0.5+/-0.9 | 1 |
| 132 | 0.87/0.9 | 1 |
| 133 | 7.7±0.9 | 1 |
| 134 | 58.2+/-36.9 | 1 |
| 135 | 3.04+/-1.09 | 1 |
| 136 | 27109 | 1 |
| 137 | d16s419 | 1 |
| 138 | n229 | 1 |
| 139 | 40,429 | 2 |
| 140 | 239.89 | 1 |
| 141 | eehv1a | 1 |
| 142 | 1,3-bis-2-chloroethylnitrosourea | 1 |
| 143 | hyperthemia | 2 |
| 144 | for-pla | 2 |
| 145 | 44gpa | 1 |
| 146 | tac/csa | 1 |
| 147 | scd/va | 1 |
| 148 | coda-cerva | 1 |
| 149 | adsorb | 51 |
| 150 | det1-specific | 1 |
| 151 | 936/mmc | 1 |
| 152 | +0.15˚c | 1 |
| 153 | +0.29˚c | 1 |
| 154 | -1.1°c | 1 |
| 155 | 39.5±0.2°c | 1 |
| 156 | 54.7°c | 1 |
| 157 | 920ºc | 1 |
| 158 | succeed | 154 |
| 159 | breast-feed | 36 |
| 160 | supine-wedged | 3 |
| 161 | sogd | 3 |
| 162 | trivial-mild | 1 |
| 163 | 9-years-old | 1 |
| 164 | 700-fold | 1 |
| 165 | 0.71-fold | 1 |
| 166 | refold | 22 |
| 167 | misfold | 6 |
| 168 | 300‑fold | 1 |
| 169 | descend | 17 |
| 170 | 'blend | 1 |
| 171 | disbud | 1 |
| 172 | stress/senescence | 1 |
| 173 | intercede | 2 |
| 174 | confide | 6 |
| 175 | reside | 154 |
| 176 | beta-blocker/thiazide | 1 |
| 177 | engage | 1,109 |
| 178 | re-engage | 7 |
| 179 | indulge | 7 |
| 180 | postchange | 4 |
| 181 | re-emerge | 7 |
| 182 | sunbathe | 1 |
| 183 | breathe | 55 |
| 184 | partake | 15 |
| 185 | feasable | 2 |
| 186 | co-assemble | 2 |
| 187 | coassemble | 3 |
| 188 | crumble | 3 |
| 189 | ensile | 1 |
| 190 | suckle | 7 |
| 191 | titusville | 2 |
| 192 | ceftadizime | 1 |
| 193 | cyclohexadiene | 1 |
| 194 | intervene | 279 |
| 195 | recombine | 8 |
| 196 | 3-bromo-l-tyrosine | 2 |
| 197 | chloramphenicol/dexamethasone | 1 |
| 198 | δscore | 3 |
| 199 | first-base | 12 |
| 200 | post-decrease | 1 |
| 201 | h+/k+/atpase | 1 |
| 202 | abscise | 5 |
| 203 | laparotomise | 1 |
| 204 | gelatinise | 1 |
| 205 | pressurise | 1 |
| 206 | intervention-response | 1 |
| 207 | up-dose | 2 |
| 208 | reperfuse | 9 |
| 209 | defecate | 22 |
| 210 | reciprocate | 5 |
| 211 | self-aggregate | 2 |
| 212 | escalate | 40 |
| 213 | fibrillate | 1 |
| 214 | ambulate | 44 |
| 215 | circulate | 41 |
| 216 | co-circulate | 3 |
| 217 | thermoregulate | 11 |
| 218 | accumulate | 501 |
| 219 | bioaccumulate | 17 |
| 220 | sporulate | 3 |
| 221 | ovulate | 39 |
| 222 | autophosphorylate | 3 |
| 223 | hallucinate | 1 |
| 224 | germinate | 27 |
| 225 | urinate | 43 |
| 226 | redonate | 2 |
| 227 | participate | 4,087 |
| 228 | co-participate | 1 |
| 229 | pupate | 4 |
| 230 | proliferate | 107 |
| 231 | co-operate | 8 |
| 232 | reintegrate | 5 |
| 233 | disintegrate | 14 |
| 234 | modify/titrate | 1 |
| 235 | micturate | 4 |
| 236 | extravasate | 6 |
| 237 | mutate | 7 |
| 238 | menstruate | 5 |
| 239 | autoactivate | 1 |
| 240 | locomote | 2 |
| 241 | disbelieve | 3 |
| 242 | conceive | 163 |
| 243 | date-five | 1 |
| 244 | thrive | 232 |
| 245 | arrive | 153 |
| 246 | calve | 6 |
| 247 | depoliticize | 1 |
| 248 | specialize | 30 |
| 249 | socialize | 8 |
| 250 | fertilize | 14 |
| 251 | crystallize | 49 |
| 252 | hyperpolarize | 2 |
| 253 | dimerize | 8 |
| 254 | vaporize | 7 |
| 255 | rr-hf | 1 |
| 256 | sirolimus-mmf | 3 |
| 257 | 6000μg/g | 1 |
| 258 | placebo/peg | 1 |
| 259 | re-cycling | 1 |
| 260 | grand-offspring | 1 |
| 261 | underheating | 1 |
| 262 | electrocardiographic-gating | 1 |
| 263 | pupating | 2 |
| 264 | sub-μg | 1 |
| 265 | 4.95/h | 1 |
| 266 | 2.47/h | 1 |
| 267 | 5.6h | 1 |
| 268 | 187h | 1 |
| 269 | 68h | 1 |
| 270 | apobh | 1 |
| 271 | reattach | 1 |
| 272 | self-weigh | 5 |
| 273 | 493/month | 1 |
| 274 | +20k | 1 |
| 275 | brownish-black | 1 |
| 276 | overpack | 1 |
| 277 | 1.1/week | 1 |
| 278 | relook | 1 |
| 279 | bask | 4 |
| 280 | 43.6g/l | 1 |
| 281 | 315.76±140.00μg/l | 1 |
| 282 | g34w/l | 1 |
| 283 | heal | 370 |
| 284 | cyclosporine-neoral | 1 |
| 285 | chest-level | 1 |
| 286 | enroll | 527 |
| 287 | re-enroll | 3 |
| 288 | self-enroll | 2 |
| 289 | reenroll | 1 |
| 290 | 1010/ml | 1 |
| 291 | 1012/ml | 1 |
| 292 | 1.2mg/ml | 2 |
| 293 | 5000ng/ml | 1 |
| 294 | 200ng/ml | 1 |
| 295 | 1.6ng/ml | 1 |
| 296 | 14.4µg/ml | 1 |
| 297 | 370mgi/ml | 1 |
| 298 | oxyphyllacinol | 2 |
| 299 | oxupurinol | 1 |
| 300 | c3-epi-cholecalciferol | 1 |
| 301 | re-enrol | 1 |
| 302 | 370.41±91.56m | 1 |
| 303 | vancomycin/aztreonam | 1 |
| 304 | 27.1mm | 1 |
| 305 | fathom | 2 |
| 306 | 6microm | 2 |
| 307 | 4pm | 3 |
| 308 | re-form | 2 |
| 309 | metoform | 1 |
| 310 | colophonium | 3 |
| 311 | thermofilum | 3 |
| 312 | vam-hldn | 1 |
| 313 | dilate/stiffen | 1 |
| 314 | awaken | 13 |
| 315 | 123/min | 2 |
| 316 | 118±11min | 1 |
| 317 | 0.52min | 1 |
| 318 | 24.7min | 1 |
| 319 | cc-gonadotropin | 1 |
| 320 | rt-pa/aspirin | 1 |
| 321 | 5fu/leucovorin | 1 |
| 322 | 5-fu-cisplatin | 1 |
| 323 | glibenclamide+rosuvastatin | 1 |
| 324 | α-chitin | 2 |
| 325 | reducion | 1 |
| 326 | sub-diffusion | 1 |
| 327 | extraction/exfoliation | 1 |
| 328 | immunodysregulation | 2 |
| 329 | myeloproliferation | 2 |
| 330 | posttitration | 3 |
| 331 | mucosalization | 3 |
| 332 | implantation/randomization | 1 |
| 333 | improvement/reduction | 1 |
| 334 | 16950euro | 1 |
| 335 | 2-amp | 1 |
| 336 | placebo+p/r | 1 |
| 337 | schröder | 2 |
| 338 | neurorepair | 3 |
| 339 | 1.61±0.58m/s | 1 |
| 340 | 8.67±1.70s | 1 |
| 341 | restingas | 1 |
| 342 | non-amlodipine-dhp-ccbs | 1 |
| 343 | scs/sccs | 2 |
| 344 | non-autistics | 1 |
| 345 | trichomanads | 1 |
| 346 | turbulences | 1 |
| 347 | post-changes | 2 |
| 348 | invalidities | 1 |
| 349 | peridomiciles | 1 |
| 350 | 2,3'-bisindoles | 1 |
| 351 | 3-cyano-4,5-dihydro-1h-pyrroles | 1 |
| 352 | alkyl-naphthalenes | 1 |
| 353 | chlorophthalazines | 2 |
| 354 | postvalues | 1 |
| 355 | 06:00hs | 1 |
| 356 | m1-cis | 2 |
| 357 | ad-oxytosis | 1 |
| 358 | playbacks | 1 |
| 359 | followup/withdrawals | 1 |
| 360 | n-h-1,3-aminoalcohols | 1 |
| 361 | placebo/controls | 1 |
| 362 | snarls | 1 |
| 363 | antimicrobians | 1 |
| 364 | afro-trinidadians | 1 |
| 365 | 3-acylfurans | 1 |
| 366 | tp53-mutations | 1 |
| 367 | post-evaluations | 1 |
| 368 | dose-reductions | 1 |
| 369 | fitc-lps | 2 |
| 370 | 3',5'-cnmps | 2 |
| 371 | metal-nps | 1 |
| 372 | ukrs | 1 |
| 373 | sub-investigators | 1 |
| 374 | regress | 142 |
| 375 | phase-shifts | 1 |
| 376 | leptocheirus | 2 |
| 377 | 142days | 1 |
| 378 | 63days | 1 |
| 379 | overeat | 9 |
| 380 | engraft | 8 |
| 381 | moderate/light | 1 |
| 382 | cel5a-xylt | 2 |
| 383 | dis-temperament | 1 |
| 384 | autosegment | 1 |
| 385 | follow-up-assessment | 1 |
| 386 | coapt | 2 |
| 387 | etancercept | 1 |
| 388 | seroconvert | 11 |
| 389 | reinvest | 4 |
| 390 | efv+3tc-zdv | 7 |
| 391 | 1.2ppmv | 1 |
| 392 | grow | 614 |
| 393 | re-grow | 2 |
| 394 | regrow | 5 |
| 395 | overgrow | 3 |
| 396 | farrow | 4 |
| 397 | bipreterax | 2 |
| 398 | neoreflux | 1 |
| 399 | 211mcg/day | 1 |
| 400 | 4500mg/day | 1 |
| 401 | subconfluency | 1 |
| 402 | liquidify | 1 |
| 403 | ovario-hysterectomy | 1 |
| 404 | miscarry | 5 |
| 405 | marry | 24 |
| 406 | freeze-injury | 2 |
| 407 | equitoxicity | 1 |
| 408 | photo-stability | 3 |
| 409 | vd₃ | 3 |
| 410 | meningitec® | 1 |
| 411 | ≥20° | 3 |
| 412 | ±20° | 1 |
| 413 | 4.25° | 2 |
| 414 | 117° | 2 |
| 415 | 17.27° | 1 |